Get ready for the next wave of pharmaceutical and medical device litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
Download a publication order form here or subscribe here.
Drugs & Medical Devices - Issue: 3
Spending on Direct-to-Consumer Drug Advertising Up $1.7 Billion; Remains Secondary to Other Marketing Strategies
The Warnings Page: New Advisories Issued On Paxil, Lotronex, Zyban, and Herbal Supplement SPES/PC SPES
Fifth Circuit Rules Duract Plaintiffs Have No Standing Absent Injury
Mississippi Judge Halves $100 Million Propulsid Verdict
Lamisil's Liver Toxicity Warnings Were Adequate, Fifth Circuit Rules
Plaintiffs Failed to Show Zoloft Misrepresentation Caused Boy's Suicide, Kansas Judge Rules
Bayer Denies Allegations in Class Action, Asserts Class Certification Is Improper
Court Rules Joinder of Metabolife Distributors Not Fraudulent
